Director Stephen F. Page of AeroVironment Inc (NASDAQ:AVAV) completed a sale of 250 shares of the company's common stock on March 2, 2026. The shares were sold at $300 each, producing a transaction value of $75,000. Since the trade, the stock price has retreated to $229.30, reflecting a drop in excess of 20% over the previous week.
Following the disposition, Mr. Page retains direct ownership of 1,705 shares. In addition, the Stephen F. Page Living Trust, for which Mr. Page serves as trustee, holds 50,001 shares of AeroVironment. The Director's sale was executed pursuant to a Rule 10b5-1 trading plan that the Stephen F. Page Living Trust adopted on September 30, 2025.
Market commentary included in InvestingPro analysis notes that AVAV is trading above its Fair Value while displaying oversold technical conditions. The analysis also flags that AeroVironment has earnings scheduled for March 10 and that AVAV's Pro Research Report is available for subscribers alongside coverage of more than 1,400 other U.S. equities.
On the corporate program front, AeroVironment is actively engaged in discussions with the U.S. Space Force over its Satellite Communications Augmentation Resource - SCAR - program contract, which involves delivery of ground stations. That contract remains paused as the parties work toward a firm-fixed-price arrangement tied to a commercialized product solution. The SCAR program accounts for a sizable portion of AeroVironment's unfunded backlog and has been reopened by the U.S. Space Force for potential competition.
Analysts have reacted to the contract status and related margin implications with a range of adjustments to price targets and risk assessments. Canaccord Genuity lowered its price target to $330 while maintaining a Buy rating, citing changes to gross margin expectations. Stifel preserved its Buy rating and its $389 price target despite the ongoing contract review. Piper Sandler reduced its price target to $290 but kept an Overweight rating, signaling heightened risk around the BADGER program. RBC Capital set its price target at $325 and indicated that SCAR's anticipated contribution to fiscal 2026 revenue has been reduced following a stop-work order.
The combination of an insider sale executed under a pre-established trading plan, a notable short-term share-price decline, paused government contract activity, and a range of analyst revisions frames the current investor narrative around AVAV. Earnings due on March 10 may provide additional data points for investors weighing valuation and operational risks tied to government program outcomes.
Investors seeking more detailed, subscription-based analysis can access AVAV's Pro Research Report through InvestingPro, which aggregates financial and technical metrics for this company alongside thousands of other U.S. equities.